Search Results - "Sethunath, V"
-
1
Drug-sensitive FGFR3 mutations in lung adenocarcinoma
Published in Annals of oncology (01-03-2017)“…Lung cancer is the leading cause of cancer-related deaths across the world. In this study, we present therapeutically relevant genetic alterations in lung…”
Get full text
Journal Article -
2
Abstract P4-03-04: Targeting the mevalonate pathway in HER2-positive breast cancer to overcome resistance to anti-HER2 therapy
Published in Cancer research (Chicago, Ill.) (15-02-2018)“…Abstract Background: Despite the advent of HER2-targeted therapies for HER2+ breast cancer (BC), including the monoclonal antibody trastuzumab (T) either alone…”
Get full text
Journal Article -
3
Abstract P6-17-12: Neratinib in combination with trastuzumab is superior to each alone and to pertuzumab plus trastuzumab in HER2-positive in vivo breast cancer models
Published in Cancer research (Chicago, Ill.) (15-02-2019)“…Abstract Background: Lapatinib (L) plus trastuzumab (T) alone or with endocrine therapy for HER2+/ER+ tumors but without chemotherapy, yielded complete tumor…”
Get full text
Journal Article -
4
Abstract P6-20-10: Role of GPR110 in breast cancer
Published in Cancer research (Chicago, Ill.) (15-02-2019)“…Abstract Our long-term goal is to discover adhesion GPCR targets in breast cancer. Our previous studies have found GPR110 to be overexpressed in tumorigenic…”
Get full text
Journal Article -
5
Drug-sensitiveFGFR3 mutations in lung adenocarcinoma
Published in Annals of oncology (01-03-2017)“…Lung cancer is the leading cause of cancer-related deaths across the world. In this study, we present therapeutically relevant genetic alterations in lung…”
Get full text
Journal Article